Misako Nagasaka

Financial relationships

  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    AstraZeneca
    Date added: 
    11/09/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    Daiichi Sankyo
    Date added: 
    11/09/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    Novartis
    Date added: 
    11/09/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    EMD Serono
    Date added: 
    11/09/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    Pfizer
    Date added: 
    11/09/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    Lilly
    Date added: 
    11/09/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    Genentech
    Date added: 
    11/09/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    Mirati
    Date added: 
    11/09/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    Caris Life Sciences
    Date added: 
    11/09/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    Takeda
    Date added: 
    11/09/2022

Pages

Return to San Diego Multidisciplinary Thoracic Oncology Symposium: Patient-centered approach to improve outcomes